
Favorable outcome of hepatosplenic candidiasis in a patient with acute leukemia
Author(s) -
Nataša Čolović,
Valentina Arsić Arsenijević,
Nada Suvajdžić,
Irena Đjunić,
Dragica Tomin
Publication year - 2015
Publication title -
srpski arhiv za celokupno lekarstvo
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.135
H-Index - 17
eISSN - 2406-0895
pISSN - 0370-8179
DOI - 10.2298/sarh1506341c
Subject(s) - medicine , gastroenterology , chemotherapy , neutropenia , fluconazole , leukemia , myeloid leukemia , immunology , antifungal , dermatology
Acute leukemias treatment requires strong chemotherapy. Patients that develop bone marrow aplasia become immunocompromised, thus becoming liable to bacterial and fungal infections. Fungal infections caused by Candida are frequent. Hepatosplenic candidiasis (HSC) is a frequent consequence of invasive candidiasis which is clinically presented with prolonged febrility unresponsive to antibiotics.